NeuroOne Medical Technologies Corporation income statement NMTC

Annual Quarterly

In fiscal 2025, which ended Sep 30, 2025, NeuroOne Medical Technologies Corporation reported revenue of $9.1 million, up 163.5% from the year before. It recorded a net loss of $3.6 million. The operating loss came to $4.2 million, an operating margin of -46.5%. Diluted earnings per share were -$0.09. Over the twelve months ended Jun 30, 2026, revenue was $9.5 million and the net loss was $7.4 million. Across the 5 fiscal years shown, revenue grew from $178,146 in fiscal 2021 to $9.1 million in fiscal 2025, about 167.3% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Jun 30, 2026	FY 2025 Sep 30, 2025	FY 2024 Sep 30, 2024	FY 2023 Sep 30, 2023	FY 2022 Sep 30, 2022	FY 2021 Sep 30, 2021	FY 2020 Sep 30, 2020	FY 2019 Sep 30, 2019	FY 2018 Dec 31, 2017	FY 2016 Dec 31, 2016	FY 2015 Dec 31, 2015
Revenue	9 +42.8%	9 +163.5%	3 +76.9%	2 +1040.7%	0 -3.9%	0	—	—	—	0	0 -100.0%
Cost of revenue	4 +46.1%	4 +66.7%	2 +58.7%	1 +518.2%	0 -12.3%	0	—	—	—	—	—
Gross profit	5 +40.4%	5 +376.2%	1 +136.5%	0 +744.9%	-0 +27.6%	-0	—	—	—	—	—
Research and development	5 +8.5%	5 -1.6%	5 -27.0%	7 +40.8%	5 +25.6%	4 +89.1%	2 +35.7%	2 +108.0%	1	—	—
Selling, general and administrative	8 +4.3%	7 -6.5%	8 +14.1%	7 -0.8%	7 +11.5%	6 +31.7%	5 +10.9%	4 +83.3%	2	0 +5.5%	0 -15.7%
Operating income	-8 -39.3%	-4 +64.4%	-12 +0.6%	-12 -19.2%	-10 +1.8%	-10 -108.4%	-5 +15.7%	-6 -89.2%	-3	-0 -5.5%	-0 +13.9%
Pretax income	-7 -39.5%	-4 +70.7%	-12 -3.9%	-12	—	—	-2	—	—	-0 -5.5%	-0 +14.7%
Income tax	—	—	—	—	—	-0	—	—	—	0	0
Net income	-7 -39.5%	-4 +70.7%	-12 -3.9%	-12 -18.6%	-10 -0.5%	-10 +27.1%	-14 -101.1%	-7 -34.1%	-5	-0 +24.0%	-0 -73.4%
Basic EPS	-0.18 +59.7%	-0.09 +80.4%	-0.46 +29.2%	-0.65 -3.2%	-0.63	—	—	—	—	—	—
Diluted EPS	-0.18 +59.8%	-0.09 +80.4%	-0.46 +29.2%	-0.65 -3.2%	-0.63	—	—	—	—	—	—
Weighted average shares, basic	42 +246.0%	40 +50.0%	27 +47.7%	18 +13.3%	16	—	—	—	—	—	—
Weighted average shares, diluted	42 +246.7%	40 +50.0%	27 +47.7%	18 +13.3%	16	—	—	—	—	—	—
Other measures
Depreciation and amortization	0 -9.4%	0 +6.0%	0 +23.9%	0 +68.0%	0 +46.9%	0 +69.6%	0 +652.6%	0	—	—	—
EBITDA	-8 -41.6%	-4 +65.9%	-12 +1.0%	-12 -18.6%	-10 +2.2%	-10 -108.8%	-5 +16.4%	-6	—	—	—
Interest coverage	—	—	—	—	-3,285.54x	—	—	—	—	—	-2.21x
Margins
Gross margin	55.65%	56.51%	31.27%	23.38%	-41.36%	-54.87%	—	—	—	—	—
Operating margin	-83.43%	-46.46%	-344.26%	-612.32%	-5,860.15%	-5,735.86%	—	—	—	—	—
Pretax margin	-78.63%	-39.63%	-356.74%	-607.42%	—	—	—	—	—	—	—
Profit margin	-78.63%	-39.63%	-356.74%	-607.42%	-5,841.95%	-5,584.28%	—	—	—	—	—
EBITDA margin	-80.93%	-43.58%	-337.11%	-602.12%	-5,790.85%	-5,690.54%	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: NMTC (Nasdaq)
Fiscal year ends: September 30
Incorporated in: DE
Headquarters: Eden Prairie, MN
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1500198
Former names: Original Source Entertainment, Inc. (until May 22, 2017)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.